Suchergebnisse - "Caballero, Estrella"

PubPharm (14)

1

The algorithm used for the interpretation of doravirine transmitted drug resistance strongly influences clinical practice and guideline recommendations

enthalten in: The Journal of antimicrobial chemotherapy | 2020

von Guerrero-Beltrán, C. | Martínez-Sanz, J. | Álvarez, M. | +24

2

Antiretroviral Therapy for HIV-2 Infection in Non-Endemic Regions

enthalten in: AIDS reviews | 2020

von Mendoza, C. | Lozano, A. | Caballero, E. | +3

3

Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain

enthalten in: AIDS (London, England) | 2019

von Requena, S. | Caballero, E. | Lozano, A. | +9

4

HIV drug resistance in Africa : an emerging problem that deserves urgent attention

enthalten in: AIDS (London, England) | 2017

von Moreno, M. | Caballero, E. | Mateus, R. | +3

5

Impact of low-level viraemia on virological failure in HIV-1-infected patients with stable antiretroviral treatment

enthalten in: Antiviral therapy | 2016

von Navarro, J. | Caballero, E. | Curran, A. | +7

6

Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent HIV-infected patients in Spain

enthalten in: AIDS patient care and STDs | 2014

von Navarro, J. | Pérez, M. | Curran, A. | +8

7

HIV-2 viral tropism influences CD4+ T cell count regardless of viral load

enthalten in: The Journal of antimicrobial chemotherapy | 2014

von Treviño, A. | Soriano, V. | Poveda, E. | +87

8

Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes

enthalten in: The Journal of antimicrobial chemotherapy | 2013

von Anta, L. | Blanco, J. | Llibre, J. | +63

9

Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

enthalten in: AIDS (London, England) | 2013

von Anta, L. | Llibre, J. | Poveda, E. | +59

10

Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

enthalten in: Retrovirology | 2012

von Betancor, G. | Garriga, C. | Puertas, M. | +52